Stephen K Doberstein's Net Worth
$24.8 Million
Who is Stephen K Doberstein?
Stephen K Doberstein has an estimated net worth of $24.8 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, NEKTAR THERAPEUTICS, and Forte Biosciences, Inc..
SEC CIK
Stephen K Doberstein's CIK is 0001480111
Past Insider Trading and Trends
2017 was Stephen K Doberstein's most active year for acquiring shares with 9 total transactions. Stephen K Doberstein's most active month to acquire stocks was the month of November. 2017 was Stephen K Doberstein's most active year for disposing of shares, totalling 14 transactions. Stephen K Doberstein's most active month to dispose stocks was the month of October. 2010 saw Stephen K Doberstein paying a total of $5,146,200.00 for 540,000 shares, this is the most they've acquired in one year. In 2018 Stephen K Doberstein cashed out on 337,086 shares for a total of $15,942,218.49, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Dicerna Pharmaceuticals Inc No price found
InvestorStephen K Doberstein used to own units in Common Stock but no longer holds any shares there. In the year 2020 Stephen K Doberstein filed a total of 5 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.33K |
$38.25 | -$127,487.25 |
0
|
Dec 28
| |||
Form 4
|
∞
| 3.33K |
—
|
—
| 3.33K |
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEKTAR THERAPEUTICS (NKTR) Snapshot price: $1.12
SVP & Chief Scientific OfficerStephen K Doberstein owns 107,668 units of Common Stock which is worth $120,588.16. In the year 2010 Stephen K Doberstein filed a total of 33 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +16.19% | 15K |
$17.28 | $259,200.00 | 107.67K |
Sep 5
| |||
Form 4
| -3.38% | -3.25K |
$18.15 | -$58,896.75 | 92.67K |
Aug 16
| |||
Form 4
| -3.48% | -3.46K |
$31.37 | -$108,571.57 | 95.91K |
May 16
| |||
Form 4
| -3.22% | -3.31K |
$42.39 | -$140,310.90 | 99.37K |
Feb 19
| |||
Form 4
| +30.42% | 23.95K |
—
|
—
| 102.68K |
Dec 14
| |||
Form 4
| -5.43% | -4.52K |
$38.25 | -$173,043.00 | 78.73K |
Nov 16
| |||
Form 4
| +30.17% | 19.3K |
$58.40 | -$391,338.40 | 83.26K |
Aug 15 - Aug 16
| |||
Form 4
| -5.10% | -3.44K |
$83.39 | -$286,444.65 | 63.96K |
May 16
| |||
Form 4
|
—
|
0
|
$50.79 | -$13,527,780.00 | 67.39K |
Scheduled
|
Apr 6 - Apr 9
| ||
Form 4
| -3.47% | -2.43K |
$82.94 | -$201,212.44 | 67.39K |
Feb 16
| |||
Form 4
| +59.33% | 26K |
—
|
—
| 69.82K |
Dec 15
| |||
Form 4
| +40.89% | 12.72K |
$44.23 | -$211,507.86 | 43.82K |
Nov 15 - Nov 16
| |||
Form 4
|
—
|
0
|
$19.27 | -$7,716,517.55 | 31.1K |
Scheduled
|
Nov 6 - Nov 8
| ||
Form 4
|
—
|
0
|
$17.25 | -$674,372.88 | 31.1K |
Scheduled
|
Oct 5
| ||
Form 4
| -5.19% | -1.70K |
$19.32 | -$32,863.32 | 31.1K |
Aug 16
| |||
Form 4
| -4.93% | -1.70K |
$19.55 | -$33,254.55 | 32.8K |
May 16
| |||
Form 4
|
—
|
0
|
$15.61 | -$1,217,000.00 | 34.5K |
Scheduled
|
Apr 5
| ||
Form 4
| -3.53% | -1.26K |
$13.14 | -$16,569.54 | 34.5K |
Feb 16
| |||
Form 4
| +95.81% | 17.5K |
—
|
—
| 35.77K |
Dec 13
| |||
Form 4
| -3.54% | -670.00 |
$13.96 | -$9,353.20 | 18.27K |
Nov 16
| |||
Form 4
| -6.59% | -1.34K |
$17.56 | -$23,460.16 | 18.93K |
Aug 16
| |||
Form 4
| +1,028.40% | 10.5K |
—
|
—
| 11.52K |
Jul 14
| |||
Form 4
| +110.52% | 536 |
$13.58 | -$4,603.53 | 1.02K |
May 16 - May 17
| |||
Form 4
|
∞
| 485 |
$11.92 | -$4,648.71 | 485 |
Feb 16 - Feb 17
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
| No matching records found | |||||||||
Forte Biosciences, Inc. (FBRX) Snapshot price: $7.85
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||